News

MediView has announced the first patient enrolment in a multi-centre study to assess the procedural efficiency of its XR90 ...
Methylation changes in microbiome-derived cfRNA enable more accurate CRC diagnosis than traditional DNA or abundance-based ...
Recurrent lupus nephritis post-transplant may go undetected without surveillance biopsies. This study reveals high recurrence ...
Liquid biopsies are tests that detect signs of cancer through a simple blood draw. Unlike traditional biopsies, which require ...
A study from the University of Chicago introduces an RNA-based liquid biopsy that detects early-stage colorectal cancer with ...
Dr. Breelyn Wilky explains how vague symptoms and testing challenges delay GIST diagnoses; however, molecular testing can ...
The global Liquid Biopsy Market is valued at USD 11.41 Billion in 2024 and is projected to reach a value of USD 30.65 Billion ...
Liquid biopsies are tests that detect signs of cancer through a simple blood draw. Unlike traditional biopsies, which require removing a piece of tissue, a liquid biopsy typically looks for mutations ...
A team of researchers from the Te Whai Ao Dodd-Walls Centre have developed a potential gamechanger in the detection and ...
New study by three Indian American researchers promises replacement of invasive surgical biopsies with blood test ...
MediView, a leader in advanced medical imaging technologies, announces the enrollment of the first patient in a clinical ...
She credited the same risk assessment test that led to her own diagnosis in 2023 with potentially saving her mother's life.